Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free BTTX Stock Alerts

Better Therapeutics (BTTX) Competitors

Better Therapeutics logo
Compare

BTTX vs. UPHL, ACONW, DHACW, LFMDP, and PIIIW

Should you buy Better Therapeutics stock or one of its competitors? MarketBeat compares Better Therapeutics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Better Therapeutics include UpHealth (UPHL), Aclarion (ACONW), Digital Health Acquisition (DHACW), LifeMD (LFMDP), and P3 Health Partners (PIIIW). These companies are all part of the "healthcare" industry.

How does Better Therapeutics compare to UpHealth?

Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

Better Therapeutics has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, UpHealth has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market.

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
UpHealth Neutral

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
UpHealth N/A N/A N/A

34.0% of Better Therapeutics shares are held by institutional investors. Comparatively, 56.1% of UpHealth shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Comparatively, 34.2% of UpHealth shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Better Therapeutics has higher earnings, but lower revenue than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.39N/A
UpHealth$130M0.00-$56.42M$1.980.00

Summary

UpHealth beats Better Therapeutics on 4 of the 7 factors compared between the two stocks.

How does Better Therapeutics compare to Aclarion?

Aclarion (NASDAQ:ACONW) and Better Therapeutics (NASDAQ:BTTX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Aclarion has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
Better TherapeuticsN/AN/A-$39.76M-$0.39N/A

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
Better Therapeutics N/A N/A N/A

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Aclarion's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company Overall Sentiment
Aclarion Neutral
Better Therapeutics Neutral

Summary

Better Therapeutics beats Aclarion on 2 of the 3 factors compared between the two stocks.

How does Better Therapeutics compare to Digital Health Acquisition?

Better Therapeutics (NASDAQ:BTTX) and Digital Health Acquisition (NASDAQ:DHACW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation.

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
Digital Health Acquisition Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.39N/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
Digital Health Acquisition N/A N/A N/A

Summary

Better Therapeutics beats Digital Health Acquisition on 2 of the 2 factors compared between the two stocks.

How does Better Therapeutics compare to LifeMD?

Better Therapeutics (NASDAQ:BTTX) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled LifeMD'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
LifeMD Neutral

LifeMD has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.39N/A
LifeMD$193.33MN/AN/AN/AN/A

34.0% of Better Therapeutics shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
LifeMD N/A N/A N/A

Summary

Better Therapeutics beats LifeMD on 2 of the 3 factors compared between the two stocks.

How does Better Therapeutics compare to P3 Health Partners?

Better Therapeutics (NASDAQ:BTTX) and P3 Health Partners (NASDAQ:PIIIW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

34.0% of Better Therapeutics shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
P3 Health Partners N/A N/A N/A

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled P3 Health Partners'average media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
P3 Health Partners Neutral

P3 Health Partners has higher revenue and earnings than Better Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.39N/A
P3 Health Partners$1.47BN/AN/AN/AN/A

Summary

Better Therapeutics beats P3 Health Partners on 2 of the 3 factors compared between the two stocks.

Get Better Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTTX vs. The Competition

Export
MetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$4K$1.37M$6.88B$12.56B
Dividend YieldN/AN/A2.67%7.39%
P/E Ratio0.00N/A27.3724.59
Price / SalesN/A0.00495.9480.64
Price / CashN/AN/A49.2456.99
Price / BookN/A0.0010.946.45
Net Income-$39.76M-$56.42M$3.57B$331.50M

Better Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTTX
Better Therapeutics
N/AN/AN/A+0.0%$4KN/AN/A40
UPHL
UpHealth
N/A$0.00
flat		N/A+50.0%$2K$130MN/A1,750
ACONW
Aclarion
N/A$0.02
-0.9%		N/A-26.4%$0.00$77.88KN/A7
DHACW
Digital Health Acquisition
N/A$0.03
flat		N/AN/A$0.00N/AN/AN/A
LFMDP
LifeMD
N/A$23.44
+0.3%		N/A-0.2%$0.00$193.33MN/A230

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BTTX) was last updated on 7/9/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel